Simultaneous Single Cell Gene Expression and EGFR Mutation Analysis of Circulating Tumor Cells Reveals Distinct Phenotypes in NSCLC
- 23 July 2020
- journal article
- research article
- Published by Wiley in Advanced Biosystems
- Vol. 4 (8), 2000110-e2000110
- https://doi.org/10.1002/adbi.202000110
Abstract
While cancer cell populations are known to be highly heterogeneous within a tumor, the current gold standard of tumor profiling is through a tumor biopsy. These biopsies are invasive and prone to missing these clones due to spatial heterogeneity, and this bulk analysis approach can miss information from rare subpopulations. To noninvasively investigate tumor cell heterogeneity, a streamlined workflow is developed to scrutinize rare cells, such as circulating tumor cells (CTCs), for simultaneous analysis of mutations and gene expression profiles at the single cell level. This powerful workflow overcomes low‐input limitations of single cell analysis techniques. The utility of this multiplexed workflow to unravel inter‐ and intra‐patient heterogeneity is demonstrated using non‐small‐cell lung cancer (NSCLC) CTCs (n = 58) from six epidermal growth factor receptor (EGFR) mutant positive NSCLC patients. CTCs are isolated using a high‐throughput microfluidic technology, the Labyrinth, and their EGFR mutation status and gene expression profiles are characterized.Keywords
Funding Information
- National Cancer Institute (P30CA046592)
- National Institutes of Health (5‐R33‐CA‐202867‐02, 1‐R01‐CA‐208335‐01‐A1, U01CA210152)
This publication has 34 references indexed in Scilit:
- Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheetsNature Nanotechnology, 2013
- Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cellsNature Biotechnology, 2012
- Circulating Tumor Cells in Breast Cancer: Detection Systems, Molecular Characterization, and Future ChallengesClinical Chemistry, 2011
- Association Between Hormone Receptor Expression and Epidermal Growth Factor Receptor Mutation in Patients Operated on for Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2011
- Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor CellsPLOS ONE, 2009
- Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancerCancer Treatment Reviews, 2009
- EGFR T790M Mutation: A Double Role in Lung Cancer Cell Survival?Journal of Thoracic Oncology, 2009
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate CancerClinical Cancer Research, 2008
- Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall SurvivalClinical Cancer Research, 2006